Visensia® – The Safety Index™
Continuum of Care
OBS Medical attends 35th Annual Cowen Health Care Conference
OBS Medical CEO – Peter Leyland, has been invited to attend this year’s 35th Annual Cowen Health Care Conference as a panel member for the Digital Therapeutics and Mobile Rx: Real World Applications and Emerging Business Models discussion.
OBS Medical’s CEO – Peter Leyland will be presenting Visensia® – The Safety Index™ at Swiss Re – “Transforming Healthcare: Telemedicine, best practice and you” event on the 24th Feb 2015.
OBS Medical is pleased to announce its selection of Arazy Group Consultants Inc.’s – LICENSALE.COM™ technology to streamline the registration of Visensia® – The Safety Index™ for new and emerging markets.
OBS Medical will be piloting Visensia® Mobile, with the aim of improving patient safety and outcomes, through the early detection of patient deterioration as a result of the continuous monitoring of three key vital signs (Heart Rate, SpO2 and Respiration Rate)
Every year OBS Medical attends the CHC Conference to showcase the latest developments in the Visensia® software and to meet with new and existing clients to share in our experiences using Visensia® to enhance patient safety.